556 filings
25-NSE
The Nasdaq Stock Market LLC
3 Mar 23
Exchange delisting
10:46am
DEFR14A
STAB
Statera Biopharma, Inc.
28 Feb 23
Revised proxy
9:06pm
DEF 14A
STAB
Statera Biopharma, Inc.
Definitive proxy
27 Feb 23
6:01am
PRE 14A
STAB
Statera Biopharma, Inc.
Preliminary proxy
15 Feb 23
9:08am
8-K
STAB
Statera Biopharma, Inc.
1 Feb 23
Material Modifications to Rights of Security Holders
4:34pm
8-A12G
STAB
Statera Biopharma, Inc.
1 Feb 23
Registration of securities
4:08pm
8-K
STAB
Statera Biopharma, Inc.
20 Jan 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:53pm
DEF 14A
STAB
Statera Biopharma, Inc.
Definitive proxy
28 Nov 22
4:19pm
PRE 14A
STAB
Statera Biopharma, Inc.
Preliminary proxy
18 Nov 22
8:02am
8-K
STAB
Statera Biopharma, Inc.
15 Nov 22
Entry into a Material Definitive Agreement
6:04am
10-Q
2022 Q3
STAB
Statera Biopharma, Inc.
Quarterly report
14 Nov 22
5:22pm
8-K
STAB
Statera Biopharma, Inc.
4 Nov 22
Entry into a Material Definitive Agreement
9:51pm
D
STAB
Statera Biopharma, Inc.
4 Nov 22
$764.50 k in equity / options, sold $577.00 k, 12 investors
6:59pm
10-Q
2022 Q2
STAB
Statera Biopharma, Inc.
Quarterly report
28 Oct 22
8:49am
8-K
STAB
Statera Biopharma, Inc.
27 Oct 22
Other Events
5:00pm
8-K
STAB
Statera Biopharma, Inc.
24 Oct 22
Statera Biopharma Files Form 10-Q and Reaches Agreement with Silverback Capital and AVOF
6:08am
10-Q
2022 Q1
STAB
Statera Biopharma, Inc.
Quarterly report
21 Oct 22
9:00am
8-K
STAB
Statera Biopharma, Inc.
17 Oct 22
Entry into a Material Definitive Agreement
5:30pm
10-K
2021 FY
STAB
Statera Biopharma, Inc.
Annual report
5 Oct 22
6:00pm
8-K
STAB
Statera Biopharma, Inc.
27 Sep 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
11:26am